CD274 and neoplasm: Therefore, PD‐L1 inhibitors binding PD‐L1 on the surface of tumor cells were used to block the immune escape PD‐1/PD‐L1 pathway and restore the immune activity of T cells, thus significantly enhancing immune response[102].